At Viatris, we aim to empower people worldwide to live healthier at every stage of life. And we know that in order to do this, we must be committed to providing steady leadership in a world that is constantly evolving. We take that commitment seriously and know that advancing sustainable operations and innovative solutions to improve patient health requires strong global leadership. We know what it takes to reach more patients with more products, and believe that Viatris is uniquely positioned to make a difference through our:
- Powerful global operating platform, which combines best-in-class manufacturing and supply chain capabilities. We have more than 50 manufacturing facilities producing oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients in five continents and 12 countries, which mitigates risk of disruption in any given part of the world. Through our commitment to advancing sustainable operations, we work to systematically and diligently minimize our environmental footprint across the Viatris network. Our integrated, comprehensive approach focuses on managing our water, air emissions, waste, climate change and energy impact.
- Robust global technical resources, including approximately 2,900 research and development, regulatory and medical experts working around the world on innovative therapies and solutions for patients everywhere.
- Strong global commercial team, including approximately 11,000 sales team members and more than 1,100 marketing professionals who ensure that products are shipped globally to more than 60,000 customers.
- Diverse and differentiated global portfolio includes products in more than 10 major therapeutic areas, including both infectious diseases and non-communicable diseases and medicines that treat 10 out of 10 of the World Health Organization’s leading causes of death. We are a leading supplier of medicines to the HIV/AIDS community around the world, with a legacy of providing access to high quality and affordable ARVs in more than 100 countries. We also are a leading provider of biosimilars globally, with more than 300 biosimilar marketing authorization approvals in more than 85 countries in the areas of oncology, immunology, endocrinology, ophthalmology and dermatology.
Viatris’ global leadership in all of these areas uniquely positions us to efficiently and effectively serve patients regardless of geography or circumstance. Together, with our commitment to provide access to a sustainable, affordable, and diverse portfolio of high-quality medicines and our goal to be a Partner of Choice™ for companies big and small, Viatris works to improve access and meet evolving healthcare needs around the world.